Samuel Blackman
Fundador en DAY ONE BIOPHARMACEUTICALS, INC. .
Fortuna: 28 M $ al 31/05/2024
Relaciones activas
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Charles York | M | 47 |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | 3 años |
Jeremy Bender | M | 52 |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | 4 años |
Natalie Holles | F | 51 |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | 3 años |
Dan Becker | M | 49 |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | 5 años |
Michael Gladstone | M | 37 |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | 5 años |
Sona Saira Ramasastry | F | 48 |
DOT Therapeutics-2, Inc.
DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA. | 3 años |
Raphaël Rousseau | M | 55 | 1 años | |
J. Garland | M | 55 | 3 años | |
Garry Nicholson | M | 69 | 2 años | |
John Josey | M | 63 | 4 años | |
William Grossman | M | 54 | - | |
Habib Dable | M | 54 | - | |
Nicole Keith | F | - | 9 años | |
Adam Dubow | M | 57 | 2 años | |
Jaa Roberson | F | - | 3 años | |
Lauren Merendino | F | 49 | 1 años | |
Laura Cooper | F | - | 2 años | |
Mike Pregih | M | - | - | |
Davy Chiodin | M | - | - |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
---|---|---|---|---|
Julie Grant | F | 41 | 5 años | |
Maggie Wilderotter | F | 69 | 4 años | |
Saqib Islam | M | 54 | - | |
Derek DiRocco | M | 43 | - | |
Eric Dobmeier | M | 55 | - | |
Badreddin Edris | M | 37 | 2 años | |
Robert F. Baltera | M | 58 |
Mavupharma, Inc.
Mavupharma, Inc. Pharmaceuticals: MajorHealth Technology Mavupharma, Inc. engages development of non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease. The company was founded by W. Michael Gallatin, Brian K. Farmer, and Robert F. Baltera, Jr. and is headquartered in Kirkland, WA. | 2 años |
Hal Barron | M | 62 | 4 años | |
Thomas Daniel | M | 70 | 3 años | |
Robin Andrulevich | F | 58 | 4 años | |
Hyam Levitsky | M | 66 | 3 años | |
Robert Azelby | M | 56 | 3 años | |
Christopher Williams | M | - | 2 años | |
Fariborz Kamal | M | 61 | 2 años | |
Jason Fontenot | M | 54 | 2 años | |
Valerie Odegard | M | 46 | 2 años | |
Christian Hordo | M | 41 | 3 años | |
Lisa Bowers | F | 51 | 2 años | |
Tina Albertson | M | 51 | 5 años |
Estadísticas
País | Relaciones | % del total |
---|---|---|
Estados Unidos | 38 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Samuel Blackman
- Red Personal